Zhongnan Medical Journal Press

Home Results

A total of 100 result was found. Results that relate to COMP

Simultaneous determination of primary volatile components in Tibetan medicine Bawei Chenxiang powders by GC

Published on Chinese Journal of Pharmacoepidemiology 2024,33(11):1247-1253.
2658 times 468 times

SU Meiyun WANG Pei LIU Yanping XIE Hebing BAIMA Danzeng

Bawei Chenxiang powders Volatile components Octyl acetate Benzylacetone Myristicin Dehydrocostus lactone Gas chromatography Content determination
Details
Research progress on chemical composition and pharmacological effects of Bupleuri radix

Published on Frontiers in Pharmaceutical Sciences 2024,28(3):507-522.
5752 times 889 times

YANG Xiwen HU Wenkai JIANG Xin ZHANG Mengmeng LIU Qiuyue LIU Shumin LU Fang

Bupleuri radix Chemical composition Bupleuri radix saponin Flavonoids Volatile oil Polysaccharides Pharmacological effect Research progress
Details
Research progress on quality control methods of traditional Chinese medicine based on artificial intelligence sense technology

Published on Frontiers in Pharmaceutical Sciences 2024,28(3):550-556.
3886 times 650 times

JIANG Rulan LEI Jieyu CHEN Wenli XU Xinjun

Intelligence sense Appearance character Quality evaluation through character identification Quality control Quality evaluation Identification of Chinese traditional medicine Component detection Deep learning Multi-source information fusion Image recognition technology Artificial intelligence
Details
Extraction purification and composition analysis of Folium hibisci mutabilis polysaccharides

Published on Frontiers in Pharmaceutical Sciences 2024,28(4):574-584.
2966 times 343 times

XIE Rui SHI Jing XU Shiyi YANG Hexiang LIN Ruoyun XU Junhao YOU Yuanyuan

Folium hibisci mutabilis Polysaccharide Extraction process Responsive surface design Isolation and purification Deproteinization Monosaccharide composition Precolumn derivatization
Details
Quality evaluation of Clematidis radix et rhizoma medicinal materials based on HPLC-QAMS multi-components quantification combined with OPLS-DA and weighted TOPSIS method

Published on Frontiers in Pharmaceutical Sciences 2024,28(4):593-604.
3035 times 385 times

FENG Xiaochuan ZHANG Jing XU Yanzhao ZHANG Rui

Clematidis radix et rhizoma High-performance liquid chromatography Stechiometry Principal component analysis Orthogonal partial least squares discriminant analysis Weighted TOPSIS method Quality evaluation
Details
Identification of the compounds of Jiegu Qili tablets and constituents absorbed into blood based on UPLC-Q-Exactive-MS technology

Published on Frontiers in Pharmaceutical Sciences 2024,28(4):605-616.
3452 times 417 times

FANG Xiaoyang ZHOU Rongrong SHEN Bingbing HE Weiwei XIAO Jie XU Jin ZENG Hongliang ZHANG Shuihan

Jiegu Qili tablets Component analysis Medicated serum Ultra performance liquid chromatography-quadrupole-exactive-mass spectrometry Chemical composition Metabolites Blood components
Details
Research progress on the effects of processing on the chemical composition and pharmacological actions of Coptis chinensis

Published on Frontiers in Pharmaceutical Sciences 2024,28(4):694-704.
3077 times 476 times

LIN Xiaodan LIU Qiqi Kuang Haixue WANG Qiuhong

Coptis chinensis Processed products Process optimization Quality evaluation Chemical composition Efficacy Pharmacological actions Clinical application
Details
Establishment of HPLC fingerprint and content determination of multiple index components in Tongchang Qingyi mixture

Published on Frontiers in Pharmaceutical Sciences 2025,29(1):50-58.
2966 times 329 times

CHEN Bilin HU Yunlian LI Xia LIU Zifan XU Qian HUANG Zhijun

Tongchang Qingyi mixture Content determination High performance liquid chromatography fingerprint Cluster analysis Principal component analysis Quality study
Details
Shandong expert consensus on comprehensive clinical evaluation of sodium-glucose cotransporter 2 inhibitors

Published on Chinese Journal of Pharmacoepidemiology 2025,34(2):205-215.
2680 times 698 times

ZHAO Quan

Sodium-glucose cotransporter 2 inhibitor Comprehensive clinical evaluation Expert consensus
Details
Improvement in quality standards of sodium oleate for pharmaceutical excipients

Published on Frontiers in Pharmaceutical Sciences 2025,29(2):210-217.
1754 times 224 times

YAN Cuixia Lyu Jing HU Chuanmei SHAO Hong ZHENG Luxia CHEN Lei

Sodium oleate Fatty acid composition Content determination Key quality attributes Quality standards Pharmaceutical excipients
Details
Determination of related substances of vitamin B2 in compound zinc, iron and calcium oral solution by HPLC

Published on Frontiers in Pharmaceutical Sciences 2025,29(2):236-242.
1824 times 222 times

LI Qi LI Xiaoyan LIU Yanming SHU Sen LI Yuxin

Compound zinc iron and calcium oral solution Vitamin B2 Related substances High performance liquid chromatography
Details
Analysis of the impact and effect of medication therapy management model on home-based coronary heart disease patients

Published on Frontiers in Pharmaceutical Sciences 2025,29(2):243-250.
1467 times 235 times

WANG Xiaoyan LIU Yaomei HUANG Xiuxiu SHU Meichun HU Jie

Medication therapy management model Coronary heart disease Home-based treatment Pharmaceutical care Outpatient pharmacy Compliance Major adverse cardiovascular events
Details
Research progress on the mechanism of Styrax and its compound in the treatment of cardio-cerebrovascular diseases

Published on Frontiers in Pharmaceutical Sciences 2025,29(2):345-354.
1538 times 260 times

MA Xiaoling HAN Dan GE Weihong YU Feng

Styrax Styrax compound Cardio-cerebrovascular diseases Mechanism of action Research progress
Details
Research progress on the analysis methods for phthalates plasticizers in pharmaceutical packaging materials and drugs

Published on Frontiers in Pharmaceutical Sciences 2025,29(3):531-540.
1079 times 228 times

JIA Feifei HAN Xiaoxu ZHAO Xia

Phthalates Plasticizer Drugs Pharmaceutical packaging materials Compatibility Safety Pretreatment Analytical methods
Details
Application progress of novel targeted drugs in precision treatment of membranous nephropathy

Published on Chinese Journal of Pharmacoepidemiology 2025,34(4):467-473.
3098 times 1793 times

CHEN Wei LI Xiaowei

Membranous nephropathy Refractory membranous nephropathy Targeted therapy Anti-CD20 monoclonal antibodies Anti-B-cell activating factor monoclonal antibodies Anti-CD38 monoclonal antibodies Proteasome inhibitors Complement inhibitors Individualized treatment
Details